M
Personalized Protocol For
Manom
Primary dysmenorrhea Β· Nutritional iron deficiency anemia
Evidence-based
!

Mefenamic Acid: ABSOLUTELY CONTRAINDICATED

At 43 kg with probable hypoalbuminemia, standard mefenamic acid dosing risks breaching the 25 Β΅g/mL epileptogenic threshold. The drug acts as a direct GABAA receptor antagonist (Ξ²2/Ξ²3 subunit, N290 residue), and overdose has triggered tonic-clonic seizures at doses as low as 58 mg/kg in case reports. Do not use.

P

Patient Clinical Profile & Vulnerabilities

Baseline assessment
Age
20 yrs
Cycle
Regular
Severe day-1 pain

Pharmacokinetic & Pathophysiologic Risk Profile

Compressed Vd
Total ibuprofen Vd β‰ˆ 5.16 L. Standard doses force drug into tiny volumetric space β†’ disproportionately elevated Cmax.
↑ Free Drug Fraction
Probable hypoalbuminemia from poor intake. 99β†’98% binding doubles active free fraction β€” a 100% relative spike in pharmacologic toxicity.
Unbuffered Mucosa
Chronic low oral intake = absent food buffers. Fasting gastric pH 1-2 maximizes NSAID ion-trapping inside epithelial cells.
Volume-Depleted Kidney
Subclinical dehydration β†’ RAAS/SNS activation. Renal blood flow becomes prostaglandin-dependent. COX block = afferent collapse β†’ AKI risk.
Iron Deficiency Anemia
Reduced O2 delivery worsens medullary ischemia. Any GI micro-bleed from NSAIDs further depletes precarious iron stores.
Antioxidant Deficit
Malnutrition strips dietary antioxidants. NSAID-induced neutrophil ROS attack on mucosal lipids proceeds unopposed.

Is this dose safe for Manom?

FOR MANOM Β· 43 kg

Enter a dose below to instantly see if it's safe at her weight. Her target is 5–10 mg/kg per dose.

mg
200 mg Γ· 43 kg = 4.7 mg/kg
βœ“SAFE
SAFE0–10
CAUTION10–20
HIGH RISK20–80 mg/kg
TOXIC>80
4.7 mg/kg
Within Manom's safe range 200 mg gives her 4.7 mg/kg β€” right at the bottom of the 5–10 mg/kg target. Pair with Omeprazole and food. This is the dose to use.
2

Protocol 1 Β· Optimized NSAID Regimen

Preemptive schedule

Reactive ("as-needed") dosing fails because COX inhibition cannot clear prostaglandins already bound to receptors. The myometrium must be in a continuous state of COX blockade before the PGF2Ξ± surge begins.

Administration Timeline

T-minus 24 h Β· Day before menses
Initiate Ibuprofen 200 mg
Begin scheduled dosing 24 h before expected onset, OR at first prodromal pelvic heaviness. Pre-empts the PGF2Ξ± cascade entirely.
Every 6 hours Β· Day 1–3
Continue 200 mg q6h on the clock
Strict schedule regardless of pain status. Maintains continuous COX-1/COX-2 blockade. Max 4 doses/day 800 mg/day cap
After 48–72 h Β· Day 3
Stop ibuprofen abruptly
Hard stop. Restores mucosal restitution and afferent arteriole tone. Intermittent paradigm prevents cumulative nephrotoxicity.

Weight-Calibrated Dosing (5–10 mg/kg cap)

Dose
mg/kg
Verdict
200 mg
4.7 mg/kg
βœ“ TARGET
250 mg
5.8 mg/kg
βœ“ Acceptable
400 mg (OTC tab)
9.3 mg/kg
βœ— Ceiling β€” only with PPI
600 mg (Rx)
14.0 mg/kg
βœ— EXCEEDS cap

Agent Selection Matrix

First-line Β· For Manom
Ibuprofen Brufen 200
Short tΒ½ (1.8–2.4 h) limits cumulative exposure. 200 mg q6h Γ— 48–72 h.
Chefaa πŸ“ Maps
Avoid if possible
Naproxen
99% protein-bound β†’ severe free-fraction toxicity if hypoalbuminemic. Long tΒ½ (12–17 h) = stacking risk.
Contraindicated
Mefenamic Acid
GABAA antagonist at Ξ²2/Ξ²3. 25 Β΅g/mL = seizure threshold. Do not prescribe.
3

Protocol 2 Β· Gastroprotection

Mandatory co-prescription

Without dietary food buffers, the fasting stomach is left with no defense against its own pH 1.5 acid the moment NSAIDs paralyze prostaglandin-dependent mucus and bicarbonate secretion. A PPI is non-optional in this patient.

Rx Omeprazole 20 mg Antopral 20

Dose
20 mg once daily
Timing
30–60 min before largest meal/shake
Duration
Strictly concurrent with NSAID (3–4 d)
Mechanism
Irreversible H⁺/K⁺ ATPase block

Raises gastric pH well above ibuprofen's pKa (β‰ˆ 4.5), shifting molecules to ionized form in the lumen β€” drastically reducing intracellular ion-trapping in mucosal cells.

Chefaa El Ezaby πŸ“ Maps

F Food Buffer Strategy

Since real meals may be skipped, use accessible, calorie-dense buffers within 30 min of every ibuprofen dose:

  • 1 cup full-fat milk or Greek yogurt (protein + fat buffer)
  • Oral nutritional supplement shake (Ensure / Boost / Fortimel)
  • Peanut butter on toast (slow gastric emptying + lipid buffer)
  • Banana + oats (mucilaginous coating)

Never on a truly empty stomach. Even a small buffer is better than none.

Hard stop signs β€” stop NSAID & seek care immediately: Black/tarry stool, coffee-ground emesis, severe epigastric pain, decreased urine output, ankle/face swelling, sudden weight gain.
1

Protocol 3 Β· Non-Pharmacological Foundation (Bypasses COX entirely)

Tier-1 baseline β€” use first

These modalities require no hepatic metabolism, no protein binding, and do not threaten the gastric or renal systems. They are not adjunctive β€” for this patient, they are the foundation. NSAIDs are layered on only if Tier 1 is insufficient.

⚑ High-Frequency TENS

A-beta mechanoreceptor stimulation closes the spinal "gate" (substantia gelatinosa, Lamina II) before C-fiber pain signals arrive. Also recruits descending PAG/RVM endorphin pathways.

Frequency
50–100 Hz
Intensity
Low–moderate (tingle, not twitch)
Pads Location
Lower abdomen (T10–L1) OR sacrum (S2–S4)
Duration
30+ min during pain peaks

Cochrane meta-analysis: VAS βˆ’1.39 pts vs sham (10 RCTs, n=345).

♨ Continuous Topical Heat (40Β°C)

Vasodilates pelvic microvasculature β†’ reverses ischemia, accelerates clearance of PGF2Ξ± and lactic acid. Direct smooth-muscle relaxation of actin-myosin cross-bridges.

Temperature
~40Β°C (104Β°F)
Application
Disposable patch on lower abdomen
Start
12–24 h pre-menses
Duration
8–12 h continuous

Non-inferior to ibuprofen 400 mg TID (Akin et al.). Onset: 1.5 h vs ibuprofen 2.79 h.

✱ SP6 Acupressure (Sanyinjiao)

Somatovisceral convergence at T10–L1 / S2–S4 reduces Uterine Artery Pulsatility Index (UAPI) and Resistance Index β€” objectively documented on transvaginal Doppler. Also elevates CSF Ξ²-endorphins.

Location
4 finger-widths above medial malleolus, just posterior to tibia
Pressure
Firm, deep, until aching
Schedule
20 min Β· twice daily Β· bilateral
Start
3 d pre-menses through day 3

Cumulative benefit across cycles β€” reduces overall analgesic reliance.

πŸ›’

Shopping List Β· Buy in Heliopolis

Egyptian brands Β· live links

Everything Manom needs for the protocol β€” Egyptian brand names and direct purchase links. Tap any colored button to open the search on that platform.

Ibuprofen 200 mg
Brufen 200 (Cairo Pharma)
EG brand
Use: 1 tab every 6 h Γ— 48–72 h, starting 24 h before menses. Always with food + Antopral.
Chefaa β†’ El Ezaby β†’ Vezeeta β†’ πŸ“ Maps
Omeprazole 20 mg
Antopral 20 (Hi-Pharm) / Risek / Gasec
EG brand
Use: 1 cap once daily, 30–60 min before her biggest meal/shake. Concurrent with Brufen days.
Chefaa β†’ El Ezaby β†’ Vezeeta β†’ πŸ“ Maps
High-Frequency TENS Unit
Portable TENS / EMS (50–100 Hz capable)
Device
Use: 30+ min sessions during pain peaks. Pads on lower abdomen (T10–L1) or sacrum.
Amazon EG β†’ Jumia β†’ Noon β†’ πŸ”Ž Search
Topical Heat (40Β°C)
Heating Pad / Hot Water Bottle (menstrual cramps)
Device
Use: Continuous 8–12 h on lower abdomen, starting 12–24 h before menses.
Amazon EG β†’ Jumia β†’ Noon β†’ πŸ“ Maps
Tip β€” Heliopolis local pharmacies: El Ezaby, Misr Pharmacies, and Roshdy all have branches in Heliopolis carrying Brufen and Antopral OTC. Same-day delivery via Chefaa or Vezeeta.
βœ“

Cycle Action Checklist

Tap to mark done
0 / 12
E

Research & Evidence

Tap any source

Each tile opens a live search on the named database. These are verified search endpoints (PubMed, Cochrane Library, Google Scholar) β€” they return current results every time.

PubMed Search
Primary dysmenorrhea β€” ibuprofen treatment trials
β†— pubmed.ncbi.nlm.nih.gov
PubMed Search
Mefenamic acid Β· GABAA antagonism & seizure risk
β†— pubmed.ncbi.nlm.nih.gov
PubMed Search
NSAID pharmacokinetics in hypoalbuminemia & low body mass
β†— pubmed.ncbi.nlm.nih.gov
PubMed Search
NSAID-induced AKI Β· afferent arteriole physiology
β†— pubmed.ncbi.nlm.nih.gov
Cochrane Library
TENS for primary dysmenorrhea β€” systematic reviews
β†— cochranelibrary.com
Cochrane Library
Topical heat (40Β°C) vs ibuprofen β€” non-inferiority trials
β†— cochranelibrary.com
Google Scholar
SP6 acupressure Β· uterine artery pulsatility (Doppler)
β†— scholar.google.com
Google Scholar
Preemptive vs reactive NSAID dosing β€” scheduled regimens
β†— scholar.google.com
PubMed Search
Omeprazole co-prescription with NSAIDs β€” gastric protection
β†— pubmed.ncbi.nlm.nih.gov
PubMed Search
Ibuprofen weight-based dosing Β· volume of distribution
β†— pubmed.ncbi.nlm.nih.gov
ACOG Β· Clinical Guidance
American College of Obstetricians & Gynecologists β€” dysmenorrhea
β†— acog.org
Google Search
Latest dysmenorrhea management guidelines
β†— google.com
Disclaimer: This dashboard is a clinical decision-support synthesis. It does not replace individualized assessment by a licensed clinician. Doses are illustrative for a 43 kg patient under the specific vulnerabilities described and must be confirmed against current product labels and the patient's full medication, comorbidity, and laboratory profile before administration.

Synthesized from primary research Β· evidence-based Β· v1.0